Type 1 Diabetes Mellitus

• FDA label_change · 2022-07-01
  FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)

  FDA approves a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk. The action updates the product labeling.

• FDA label_change · 2016-06-24
  FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)

  The FDA approved a supplemental application for Tresiba (insulin degludec) from Novo Nordisk, resulting in a labeling change.

• FDA label_change · 2015-03-03
  FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)

  FDA approved a supplemental labeling application for APIDRA (insulin glulisine) from Sanofi-aventis U.S. LLC, updating the product labeling.

• FDA label_change · 2013-05-31
  FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)

  FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company.

• FDA label_change · 2013-03-09
  FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)

  The FDA approved a Novo Nordisk supplemental application for LEVEMIR (insulin detemir), updating the product labeling.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2013-02-15
  FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)

  FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by sanofi-aventis U.S. LLC, resulting in a labeling update …

• FDA label_change · 2012-01-30
  FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)

  The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.

• FDA label_change · 2007-01-26
  FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)

  FDA approved a supplemental application for NovoLOG (insulin aspart) submitted by Novo Nordisk, updating the product labeling.